SOLVE FSHD's Request for Proposals – 2025 funds innovative research to develop new treatments for facioscapulohumeral muscular dystrophy and aims for impactful advances by 2027.
Funder: SOLVE FSHD
Due Dates (Anticipated): June 2027 (Application deadline, projected)
Funding Amounts: Up to $300,000 USD total per award (max 2 years; max 10% indirect costs)
Summary: Supports innovative research to advance novel treatments for facioscapulohumeral muscular dystrophy (FSHD) by 2027.
Key Information: Lead applicant must be based at an academic or research institution.
This annual grants program from SOLVE FSHD is designed to accelerate the development of new therapies for facioscapulohumeral muscular dystrophy (FSHD), a rare progressive neuromuscular disease with no current cure. The Request for Proposals targets innovative projects that can deliver meaningful progress toward novel FSHD treatments by the end of 2027. The initiative is part of a larger $100 million commitment to catalyze impactful scientific advances and ultimately solve FSHD.